跳至主要内容
临床试验/NCT02051452
NCT02051452已完成1 期

Reversal of General Anesthesia With Intravenous Methylphenidate

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2014年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
32
试验地点
1
主要终点
Number of Participants With Adverse Events

研究概览

简要总结

The aim of this study is to investigate whether methylphenidate (Ritalin) can actively induce emergence from general anesthesia in patients having a pancreaticoduodenectomy (Whipple procedure), a pancreatectomy, or a prostatectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-75 years
  • American Society of Anesthesiologists classification 1 or 2
  • Scheduled to undergo a pancreaticoduodenectomy or distal pancreatectomy at Massachusetts General Hospital

排除标准

  • American Society of Anesthesiologists physical status classification of 3 or beyond.

研究组 & 干预措施

Methylphenidate

Experimental

Methylphenidate

干预措施: Methylphenidate (Drug)

placebo

Placebo Comparator

Saline

干预措施: Saline (Other)

结局指标

主要结局

Number of Participants With Adverse Events

时间窗: 12 months

Recorded as a measure of safety and tolerability

次要结局

  • Time to Emergence From General Anesthesia(1-4 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ken Solt

Associate Professor of Anesthesia

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验

Reversal of General Anesthesia With Methylphenidate | 临床试验